<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Access Maced J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Open Access Maced J Med Sci</journal-id><journal-title-group><journal-title>Open Access Macedonian Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="epub">1857-9655</issn><publisher><publisher-name>Institute of Immunobiology and Human Genetics</publisher-name><publisher-loc>Republic of Macedonia</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27275340</article-id><article-id pub-id-type="pmc">4884227</article-id><article-id pub-id-type="publisher-id">OAMJMS-4-102</article-id><article-id pub-id-type="doi">10.3889/oamjms.2016.025</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Science</subject></subj-group></article-categories><title-group><article-title>Evaluation of Maternal Complications in Severe Preeclampsia in a University Hospital in Tirana</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ndoni</surname><given-names>Eriseida</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Hoxhallari</surname><given-names>Redi</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bimbashi</surname><given-names>Astrit</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label><italic>University Hospital of Obstetrics and Gynecology &#x0201c;Ko&#x000e7;o Gliozheni&#x0201d;, Tirana, Albania</italic></aff><aff id="aff2"><label>2</label><italic>Italian Clinic &#x0201c;San Antonio&#x0201d;, Tirana, Albania</italic></aff><author-notes><corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Dr. Eriseida Ndoni. University Hospital of Obstetrics and Gynecology &#x0201c;Koco Gliozheni&#x0201d;, Obstetrics and Gynecology, Bulevardi &#x0201c;Bajram Curri&#x0201d;, Tirana 1001, Albania. Phone: 00355692160629. E-mail: <email xlink:href="erisandoni@yahoo.com">erisandoni@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><day>15</day><month>3</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>24</day><month>2</month><year>2016</year></pub-date><volume>4</volume><issue>1</issue><fpage>102</fpage><lpage>106</lpage><history><date date-type="received"><day>21</day><month>1</month><year>2016</year></date><date date-type="rev-recd"><day>17</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>18</day><month>2</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2016 Eriseida Ndoni, Redi Hoxhallari, Astrit Bimbashi.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><sec id="st1"><title>BACKGROUND:</title><p>Preeclampsia is a hypertensive multisystem disorder of pregnancy that complicates up to 10% of pregnancies worldwide and is one of the leading causes of maternal and perinatal morbidity and mortality.</p></sec><sec id="st2"><title>AIM:</title><p>To evaluate maternal complications associated with severe preeclampsia.</p></sec><sec id="st3"><title>METHODS:</title><p>This is a retrospective cross-sectional study conducted in the UHOG &#x0201c;Ko&#x000e7;o Gliozheni&#x0201d;, in Tirana. Primary outcomes evaluated: maternal death, eclampsia, stroke, HELLP syndrome, and pulmonary edema. Secondary outcomes: renal failure, admission in ICU, caesarean section, placental abruption, and postpartum hemorrhage. Fisher&#x02019;s exact test and Chi-squared test were used as statistical methods.</p></sec><sec id="st4"><title>RESULTS:</title><p>In women with severe preeclampsia we found higher rates of complications comparing to the group with preeclampsia. Eclampsia (1.5% vs. 7.1%, P &#x0003c; 0.001), HELLP syndrome (2.4% vs. 11.0%; P &#x0003c; 0.001), stroke (0.5% vs 1.9%, P = 0.105) pulmonary edema (0.25% vs. 1.3%, P = 0.0035), renal failure (0.9% vs. 2.6%, P = 0.107), admission in ICU (19.5% vs. 71.4%, P = 0.007), caesarean section rates (55.5% vs. 77%, P = 0.508), placental abruption (4.3% vs. 7.8%, P = 0.103) and severe postpartum hemorrhage (3.2% vs. 3.9%, P = 0.628).</p></sec><sec id="st5"><title>CONCLUSION:</title><p>Severe preeclampsia is associated with high rates of maternal severe morbidity and early diagnosis and timely intervention can prevent life treating complications.</p></sec></abstract><kwd-group><kwd>severe preeclampsia</kwd><kwd>eclampsia</kwd><kwd>HELLP syndrome</kwd><kwd>stroke</kwd><kwd>pulmonary edema</kwd><kwd>maternal outcome</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Preeclampsia is a hypertensive multisystem disorder of pregnancy that complicates up to 10% of pregnancies worldwide and is one of the leading causes of maternal and perinatal morbidity and mortality [<xref rid="ref1" ref-type="bibr">1</xref>]. Hypertension in pregnancy should be defined as a systolic blood pressure &#x02265; 140 mmHg and/or diastolic blood pressure &#x02265; 90 mmHg, based on the average of at least 2 measurements, taken at least 15 minutes apart, using the same arm [<xref rid="ref2" ref-type="bibr">2</xref>]. The diagnostic criteria of preeclampsia used to be de novo hypertension after 20 weeks of pregnancy and proteinuria (exceeding 300 mg of total protein in a 24-hour urine collection) [<xref rid="ref3" ref-type="bibr">3</xref>]. Recently, Royal College of Obstetricians and Gynecologists (RCOG) have proposed another mode of proteinuria assessment, using spot urine measuring the protein to creatinine ratio. According to the fact that preeclampsia is considered a multi-system disorder, the diagnostic criteria such as hypertension and proteinuria alone is not sufficient for clinical practice. Hence, this disease can be presented in several ways and it is necessary to asses all the symptoms and signs that are suggestive for the presence of the disease. The above mentioned facts has led to widening of the preeclampsia definition including: de novo hypertension after 20 weeks&#x02019; gestation and new onset of one of the following: a) proteinuria as defined above; b) renal insufficiency (creatinine &#x0003e; 0.09 mmol/L, or oliguria; c) liver disease (elevated transaminases and/or severe right upper quadrant or epigastric pain); d) neurological problems, convulsions (eclampsia), hyperreflexia with clonus, severe headaches, persistent visual disturbances; e) hematological disturbances: thrombocytopenia, DIC (Disseminated Intravascular Coagulation), hemolysis; or f) fetal growth restriction [<xref rid="ref4" ref-type="bibr">4</xref>].</p><p>According to American College of Obstetrics and Gynecology (ACOG) diagnostic criteria, the diagnosis of severe preeclampsia includes severe hypertension (systolic blood pressure &#x02265; 160 mmHg or diastolic blood pressure &#x02265; 110 mmHg, or both), neurological disturbances (such as headache, visual disturbances, and exaggerated tendon reflexes), epigastric or right upper quadrant pain, oliguria (less than 500 mL in 24 hours), pulmonary edema, cyanosis, impaired liver function, thrombocytopenia or intrauterine growth restriction (IUGR) [<xref rid="ref5" ref-type="bibr">5</xref>].</p><p>Preeclampsia and eclampsia account for 10&#x02013;15% of maternal deaths worldwide [<xref rid="ref6" ref-type="bibr">6</xref>]. A majority of deaths in developing countries result from eclampsia, meanwhile in developed countries result from the complications of preeclampsia (HELLP syndrome, eclampsia, DIC, renal failure, pulmonary edema) [<xref rid="ref7" ref-type="bibr">7</xref>]. HELLP syndrome occurs in 0.1%-0.6% of all pregnancies and in 4%-12% of patients with preeclampsia. HELLP syndrome typically occurs between week 27 of gestation and delivery, or immediately postpartum in 15%-30% of cases [<xref rid="ref8" ref-type="bibr">8</xref>, <xref rid="ref9" ref-type="bibr">9</xref>]. Eclampsia refers to the occurrence of new-onset, generalized, tonic-clonic seizures or coma in a woman with preeclampsia. Despite advances in detection and management, eclampsia remains a common cause of maternal morbidity and death.</p><p>Disseminated intravascular coagulation (DIC) was defined as platelet count &#x0003c; 100 000/mm<sup>3</sup>, plasma fibrinogen &#x0003c;3 g/L, and fibrin degradation products &#x0003e; 40 mg/dL [<xref rid="ref10" ref-type="bibr">10</xref>]. The prevalence of DIC in pregnancy ranges from 0.03 to 0.35 percent in population-based studies [<xref rid="ref11" ref-type="bibr">11</xref>].</p><p>Acute renal failure was diagnosed in the presence of oliguria or anuria in association with a creatinine clearance &#x02264; 20 mL/min or serum creatinine &#x02265; 2 mg/dL. Pulmonary edema is a rare and serious problem that complicates about 3 % of cases of severe preeclampsia [<xref rid="ref7" ref-type="bibr">7</xref>].</p><p>The objective of this study is to evaluate major maternal complications associated with preeclampsia and severe preeclampsia.</p></sec><sec sec-type="material|methods" id="sec1-2"><title>Material and Methods</title><p>This is a retrospective case control study conducted in the University Hospital of Obstetrics and Gynecology (UHOG) &#x0201c;Ko&#x000e7;o Gliozheni&#x0201d;, in Tirana. To collect the data for this study we used the medical records of deliveries from January 2009 until December 2013.</p><p>This study was approved by Institutional Review Board of UHOG &#x0201c;Ko&#x000e7;o Gliozheni&#x0201d;. Written informed consent was not obtained from pregnant women involved in this study, because it was a retrospective research and it was not possible to get the informed consent from every patient. The data collected for this study are anonymous.</p><p>The standard inclusion criteria in the study were pregnant women diagnosed with preeclampsia that had delivered in this hospital after 24 weeks gestation during the period mentioned above, despite the number of the babies, fetal presentation and mode of delivery.</p><p>The calculation of gestational age was made based on the first day of the last menstruation period (LMP &#x02013; 13% of cases), on the early ultrasound examination (before 13 weeks gestation &#x02013; 11% of cases) or based in the combination of both criteria (LMP and first ultrasound examination &#x02013; 76% of cases).</p><p>The exclusion criteria in this study were: pregnancies with confirmed fetal lethal anomalies, pregnancies with missing data necessary for the study, pregnancies with inaccurate gestational age.</p><p>The variables collected from the medical records were: maternal age, parity, first day of the last menstruation (LPM), gestational age at the moment of severe preeclampsia diagnosis, gestational age at delivery, highest diastolic/systolic BP, medical treatment (antihypertensives, anticonvulsants, corticoids) as well as labor and delivery &#x02013; spontaneous, induced or caesarean section (see <xref ref-type="table" rid="T1">Table 1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Maternal variables included in the study</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Maternal variables</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Maternal age</td></tr><tr><td align="left" rowspan="1" colspan="1">Parity</td></tr><tr><td align="left" rowspan="1" colspan="1">First day of the last menstruation (LPM)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gestational age at the moment of severe preeclampsia diagnosis</td></tr><tr><td align="left" rowspan="1" colspan="1">Gestational age at delivery</td></tr><tr><td align="left" rowspan="1" colspan="1">Highest diastolic BP, Highest systolic BP</td></tr><tr><td align="left" rowspan="1" colspan="1">Highest proteinuria level</td></tr><tr><td align="left" rowspan="1" colspan="1">Medical treatment (antihypertensives, anticonvulsants, corticoids)</td></tr><tr><td align="left" rowspan="1" colspan="1">Labor and delivery &#x02013; spontaneous, induced, caesarean section</td></tr></tbody></table></table-wrap><p>The maternal outcomes measured were:</p><p>Primary outcomes that include: maternal mortality, eclampsia, stroke, HELLP syndrome (hemolysis, elevated liver enzymes and low platelets), and pulmonary edema. Pulmonary edema was assessed based on clinical findings and chest radiography.</p><p>Secondary outcomes that include: renal failure, admission in ICU (Intensive Care Unit), caesarean section, placental abruption, and postpartum hemorrhage. Renal failure was diagnosed when oliguria or anuria in association with an elevated serum creatinine level &#x02265; 2 mg/dL.</p><p>All the data were collected in excel format and were checked for their completeness and accuracy. The evaluated variables were compared between the preeclampsia group and the severe preeclampsia group.</p><p>The statistical analysis was made using SPSS program. Differences between groups for categorical variables were examined with Fisher&#x02019;s exact test. In the situations with large numeric data of the variables we have used the &#x0201c;Chi-squared&#x0201d; test.</p></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>The total number of deliveries for this 5 years period (January 2009 until December 2013) was 21,795. After a careful investigation of medical records, were identified 1274 cases hospitalized with hypertensive disorders, of which 897 were diagnosed with preeclampsia.</p><p>Based on the exclusion criteria we found 27 pregnancies with confirmed fetal lethal anomalies, 99 pregnancies with missing data necessary for the study (in the medical records there were not all the available data for the variables included in the study), 28 pregnancies with inaccurate determination of gestational age (the patient doesn&#x02019;t know the LMP and/or hasn&#x02019;t done an ultrasound examination in the first trimester).</p><p>After the application of the exclusion criteria, a total of 743 cases with preeclampsia were included in this study. Based on ACOG classification criteria (2013) for the severity of the diseases we found 154 cases with severe preeclampsia (0.7% of the total births of the study period and 20.7% of all cases with preeclampsia).</p><p>Taking into consideration the fact that our study extends in a 5-year period, the population available to this study do not allow for analysis of maternal mortality. For this reason, regardless of maternal mortality is considered as the most important parameter in the evaluation of maternal outcome, referring to the small sample of this study, it was impossible the statistical processing of the results on this variable.</p><p>Eclampsia and HELLP syndrome are considered almost exclusively as unique complications of preeclampsia. For this reason the number of cases with eclampsia and HELLP syndrome is equal in both preeclampsia and severe preeclampsia groups.</p><sec id="sec2-1"><title>Primary maternal outcomes</title><p>In <xref ref-type="table" rid="T2">Table 2</xref> are presented the major maternal complications in cases with preeclampsia and severe preeclampsia (primary outcomes) and comparison was done between the two the groups for all the outcomes. In this comparison we noted a statistically significant difference for the presence of eclampsia (1.5% vs. 7.1%, for total preeclampsia group vs. severe preeclampsia group respectively; <italic>P</italic> &#x0003c; 0.001). The same significance was observed even for HELLP syndrome (2.4% vs. 11.0%; <italic>P</italic> &#x0003c; 0.001). Stroke and pulmonary edema were more frequent in the severe preeclampsia group but this difference was not statistically significant (<italic>P</italic> = 0.105 and <italic>P</italic> = 0.0035 respectively).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Primary maternal outcomes in severe preeclampsia and in total cases with preeclampsia</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Primary maternal outcomes</th><th align="center" rowspan="1" colspan="1">Total preeclampsia n (%)</th><th align="center" rowspan="1" colspan="1">Severe preeclampsia n (%)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Eclampsia</td><td align="center" rowspan="1" colspan="1">11/743 (1.5%)</td><td align="center" rowspan="1" colspan="1">11/154 (7.1%)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">HELLP syndrome</td><td align="center" rowspan="1" colspan="1">18/743 (2.4%)</td><td align="center" rowspan="1" colspan="1">18/154 (11.0%)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke</td><td align="center" rowspan="1" colspan="1">4/743 (0.5%)</td><td align="center" rowspan="1" colspan="1">3/154 (1.9%)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.105</td></tr><tr><td align="left" rowspan="1" colspan="1">Pulmonary edema</td><td align="center" rowspan="1" colspan="1">2/743 (0.25%)</td><td align="center" rowspan="1" colspan="1">2/154 (1.3%)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.0035</td></tr></tbody></table></table-wrap></sec><sec id="sec2-2"><title>Secondary maternal outcomes</title><p>In <xref ref-type="table" rid="T3">Table 3</xref> are presented the rates of secondary outcomes for both groups. In the comparison between the two groups we noted a statistically significant difference for the admission in ICU (19.5% vs. 71.4%, for total preeclampsia group vs. severe preeclampsia group respectively; <italic>P</italic> = 0.007).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Secondary maternal outcomes in severe preeclampsia and in total cases with preeclampsia</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Secondary maternal outcomes</th><th align="center" rowspan="1" colspan="1">Total preeclampsia n (%)</th><th align="center" rowspan="1" colspan="1">Severe preeclampsia n (%)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Renal failure</td><td align="center" rowspan="1" colspan="1">7/743 (0.9%)</td><td align="center" rowspan="1" colspan="1">4/154 (2.6%)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.107</td></tr><tr><td align="left" rowspan="1" colspan="1">Admission in ICU</td><td align="center" rowspan="1" colspan="1">145/743 (19.5%)</td><td align="center" rowspan="1" colspan="1">110/154 (71.4%)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">Caesarean section</td><td align="center" rowspan="1" colspan="1">413/743 (55.5%)</td><td align="center" rowspan="1" colspan="1">118/154 (77%)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.508</td></tr><tr><td align="left" rowspan="1" colspan="1">Placental abruption</td><td align="center" rowspan="1" colspan="1">32/743 (4.3%)</td><td align="center" rowspan="1" colspan="1">12/154 (7.8%)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.103</td></tr><tr><td align="left" rowspan="1" colspan="1">Severe PPH<xref ref-type="table-fn" rid="t3f1">*</xref></td><td align="center" rowspan="1" colspan="1">24/743 (3.2%)</td><td align="center" rowspan="1" colspan="1">6/154 (3.9%)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.628</td></tr></tbody></table><table-wrap-foot><fn id="t3f1"><label>*</label><p>Severe Postpartum hemorrhage (&#x0003e; 1000 mL).</p></fn></table-wrap-foot></table-wrap><p>The rate of renal failure resulted higher in women with severe preeclampsia than in women with preeclampsia, but the difference was not significant (0.9% vs. 2.6%, <italic>P</italic> = 0.107). The same results we had even for caesarean section rates (55.5% vs. 77%, <italic>P</italic> = 0.508), placental abruption (4.3% vs. 7.8%, <italic>P</italic> = 0.103) and severe postpartum hemorrhage (3.2% vs. 3.9%, <italic>P</italic> = 0.628).</p></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>Pre-eclampsia constitutes a major source of morbidity and mortality worldwide. Overall, 10%&#x02013;15% of maternal deaths are directly associated with severe preeclampsia and eclampsia [<xref rid="ref6" ref-type="bibr">6</xref>]. Although maternal mortality is a very important parameter in the evaluation of maternal outcome, referring to the small sample study, we considered impossible the statistical processing of the results on this variable.</p><p>Maternal complications generally correlated with the severity of preeclampsia. In our study we found that 1.5% of all preeclamptic women and 7.1% of all severe preeclamptic women were complicated by eclamptic seizures. In a previous study, Liu et al. demonstrated that 9.34% of cases with severe preeclampsia had eclampsia [<xref rid="ref12" ref-type="bibr">12</xref>], which is slightly higher than our results.</p><p>Our study showed that, 2.4% of cases with preeclampsia and 11% of cases with severe preeclampsia had HELLP syndrome. Also Murphy and Stirrat found that 21% of cases with severe preeclampsia had HELLP syndrome which is almost the double of our result (21% vs. 11%) [<xref rid="ref13" ref-type="bibr">13</xref>].</p><p>In our study we found stroke in 0.5% of cases with preeclampsia and 1.9% of cases with severe preeclampsia. Comparing to the literature in the PIERS study CNS complications were found 7 from 2020 cases with preeclampsia (0.35%), similar to our result for the preeclampsia group [<xref rid="ref14" ref-type="bibr">14</xref>].</p><p>As well, our study we found pulmonary edema in 1.3% of cases with severe preeclampsia. This result is higher than the results found by Yildirim et al. (5/903 cases, 0.6%) [<xref rid="ref15" ref-type="bibr">15</xref>], and lower than the results found in Tuffnell et al. (25/1087 cases, 2.3%) [<xref rid="ref16" ref-type="bibr">16</xref>]</p><p>In our study cesarean delivery rate in severe preeclampsia group was 77 %. Similar to our study we found increased rates of caesarean section in even in the studies of Liu et al. [12 Error! Reference source not found.] and Murphy and Stirrat [<xref rid="ref13" ref-type="bibr">13</xref>] (87.3 and 80 % respectively). In our study 7.8 % of cases with severe preeclampsia presented placental abruption which is less than the rate of 15% reported by Murphy and Stirrat [<xref rid="ref13" ref-type="bibr">13</xref>].</p><p>Yildirim et al. in their study found renal failure in 14 of 903 cases with severe preeclampsia (1.6%) while in our study we found renal failure in 4 of 154 cases (2.6%) [<xref rid="ref15" ref-type="bibr">15</xref>].</p><p>We concluded that severe preeclampsia is associated with high rates of maternal severe morbidity. Early diagnosis and timely intervention can prevent life threating complications from this disorder and can improve maternal outcomes.</p></sec></body><back><ack><title>Acknowledgements</title><p>We thank the statistic office in the University Hospital of Obstetrics and Gynaecology &#x0201c;Ko&#x000e7;o Gliozheni&#x0201d; for the assistance with the data collection and our colleagues in the Pathology of Pregnancy Clinic for their great work.</p></ack><fn-group><fn fn-type="other"><p><bold>Competing Interests:</bold> The authors have declared that no competing interests exist.</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>JM</given-names></name><name><surname>August</surname><given-names>PA</given-names></name><name><surname>Bakris</surname><given-names>G</given-names></name><name><surname>Barton</surname><given-names>JR</given-names></name><name><surname>Bernstin</surname><given-names>IM</given-names></name></person-group><article-title>The American College of Obstetricians and Gynecologists&#x02019;Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy</article-title><source>Obstetrics &#x00026; Gynaecology</source><year>2013</year><volume>122</volume><issue>5</issue><fpage>1122</fpage><lpage>1131</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1097/01aAOG.0000437382.03963.88">http://dx.doi.org/10.1097/01aAOG.0000437382.03963.88</uri></comment><comment>PMid:24150027</comment></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magee</surname><given-names>LA</given-names></name><name><surname>Pels</surname><given-names>A</given-names></name><name><surname>Helewa</surname><given-names>M</given-names></name><name><surname>Rey</surname><given-names>E</given-names></name><name><surname>von Dadelszen</surname><given-names>P</given-names></name><etal/></person-group><article-title>Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy:executive summary</article-title><source>J Obstet Gynaecol Can</source><year>2014</year><volume>36</volume><issue>5</issue><fpage>416</fpage><lpage>438</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/S1701-2163(15)30588-0">http://dx.doi.org/10.1016/S1701-2163(15)30588-0</uri></comment><pub-id pub-id-type="pmid">24927294</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davey</surname><given-names>DA1</given-names></name><name><surname>MacGillivray</surname><given-names>I</given-names></name></person-group><article-title>The classification and definition of the hypertensive disorders of pregnancy</article-title><source>Am J Obstet Gynecol</source><year>1988</year><volume>158</volume><issue>4</issue><fpage>892</fpage><lpage>8</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/0002-9378(88)90090-7">http://dx.doi.org/10.1016/0002-9378(88)90090-7</uri></comment><pub-id pub-id-type="pmid">3364501</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Lindheimer</surname><given-names>MD</given-names></name><name><surname>de Swiet</surname><given-names>M</given-names></name><name><surname>Van Assche</surname><given-names>A</given-names></name><name><surname>Moutquin</surname><given-names>JM</given-names></name></person-group><article-title>The classification and diagnosis of the hypertensive disorders of pregnancy:statement from the International Society for the Study of Hypertension in Pregnancy</article-title><source>Hypertens Pregnancy</source><year>2001</year><volume>20</volume><issue>1</issue><fpage>9</fpage><lpage>14</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1081/PRG-100104165">http://dx.doi.org/10.1081/PRG-100104165</uri></comment><comment>PMid:12044323</comment></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><article-title>American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists&#x02019; Task Force on Hypertension in Pregnancy</article-title><source>Obstet Gynecol</source><year>2013</year><volume>122</volume><fpage>1122</fpage><comment>PMid:24150027</comment><pub-id pub-id-type="pmid">24150027</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duley</surname><given-names>L</given-names></name></person-group><article-title>The global impact of pre-eclampsia and eclampsia</article-title><source>Semin Perinatol</source><year>2009</year><volume>33</volume><fpage>130</fpage><lpage>137</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1053/j.semperi.2009.02.010">http://dx.doi.org/10.1053/j.semperi.2009.02.010</uri></comment><comment>PMid:19464502</comment><pub-id pub-id-type="pmid">19464502</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JA</given-names></name></person-group><article-title>Diagnosis and management of preeclampsia:an update</article-title><source>Int J Women&#x02019;s Health</source><year>2010</year><volume>2</volume><fpage>327</fpage><lpage>337</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.2147/IJWH.S8550">http://dx.doi.org/10.2147/IJWH.S8550</uri></comment><comment>PMid:21151680 PMCid:PMC2990902</comment><pub-id pub-id-type="pmid">21151680</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sibai</surname><given-names>BM</given-names></name><name><surname>Ramamdan</surname><given-names>MK</given-names></name><name><surname>Usta</surname><given-names>I</given-names></name><name><surname>Salama</surname><given-names>M</given-names></name><name><surname>Mercer</surname><given-names>BM</given-names></name><name><surname>Friedman</surname><given-names>SA</given-names></name></person-group><article-title>Maternal morbidity and mortality in 442 pregnancies with HELLP syndrome</article-title><source>Am J Obstet Gynecol</source><year>1993</year><volume>169</volume><fpage>1000</fpage><lpage>6</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/0002-9378(93)90043-I">http://dx.doi.org/10.1016/0002-9378(93)90043-I</uri></comment><pub-id pub-id-type="pmid">8238109</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rath</surname><given-names>W</given-names></name><name><surname>Faridi</surname><given-names>A</given-names></name><name><surname>Dudenhausen</surname><given-names>JW</given-names></name></person-group><article-title>HELLP syndrome</article-title><source>J Perinat Med</source><year>2000</year><volume>28</volume><fpage>249</fpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1515/JPM.2000.033">http://dx.doi.org/10.1515/JPM.2000.033</uri></comment><comment>PMid:11031696</comment><pub-id pub-id-type="pmid">11031696</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sibai</surname><given-names>B.M</given-names></name></person-group><article-title>Diagnosis, controversies, and management of the sindrome of hemolysis, elevated liver enzymes, and low platelet count</article-title><source>Obstet Gynecol</source><year>2004</year><volume>103</volume><fpage>981</fpage><lpage>991</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1097/01aAOG.0000126245.35811.2a">http://dx.doi.org/10.1097/01aAOG.0000126245.35811.2a</uri></comment><comment>PMid:15121574</comment><pub-id pub-id-type="pmid">15121574</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rattray</surname><given-names>DD</given-names></name><name><surname>O&#x02019;Connell</surname><given-names>CM</given-names></name><name><surname>Baskett</surname><given-names>TF</given-names></name></person-group><article-title>Acute disseminated intravascular coagulation in obstetrics:a tertiary centre population review (1980 to 2009)</article-title><source>J Obstet Gynaecol Can</source><year>2012</year><volume>34</volume><fpage>341</fpage><comment>PMid:22472333</comment><pub-id pub-id-type="pmid">22472333</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Ching-ming</given-names></name><name><surname>Cheng</surname><given-names>Po-Jen</given-names></name><name><surname>Chang</surname><given-names>Shuenn-Dyh</given-names></name></person-group><article-title>Maternal complications and perinatal outcomes associated with gestational hypertension and severe preeclampsia in Taiwanese women</article-title><source>J Formos Med Assoc</source><year>2008</year><volume>107</volume><issue>2</issue><fpage>129</fpage><lpage>138</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/S0929-6646(08)60126-6">http://dx.doi.org/10.1016/S0929-6646(08)60126-6</uri></comment><pub-id pub-id-type="pmid">18285245</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>DJ</given-names></name><name><surname>Stirrat</surname><given-names>GM</given-names></name></person-group><article-title>Mortality and morbidity associated with early-onset preeclampsia</article-title><source>Hypertens Pregnancy</source><year>2000</year><volume>19</volume><issue>2</issue><fpage>221</fpage><lpage>231</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1081/PRG-100100138">http://dx.doi.org/10.1081/PRG-100100138</uri></comment><pub-id pub-id-type="pmid">10877990</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>TW</given-names></name><name><surname>Payne</surname><given-names>B</given-names></name><name><surname>Qu</surname><given-names>Z</given-names></name><name><surname>Hutcheon</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Magee</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia:data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study</article-title><source>J Obstet Gynaecol Can</source><year>2011</year><volume>33</volume><fpage>803</fpage><lpage>9</lpage><comment>PMid:21846435</comment><pub-id pub-id-type="pmid">21846435</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Y&#x00131;ld&#x00131;r&#x00131;m</surname><given-names>G</given-names></name><name><surname>G&#x000fc;ng&#x000f6;rd&#x000fc;k</surname><given-names>K</given-names></name><name><surname>Aslan</surname><given-names>H</given-names></name><name><surname>G&#x000fc;l</surname><given-names>A</given-names></name><name><surname>Bayraktar</surname><given-names>M</given-names></name><name><surname>Ceylan</surname><given-names>Y</given-names></name></person-group><article-title>Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome</article-title><source>J Turkish-German Gynecol Assoc</source><year>2011</year><volume>12</volume><issue>2</issue><fpage>90</fpage><lpage>96</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.5152/jtgga.2011.22">http://dx.doi.org/10.5152/jtgga.2011.22</uri></comment><comment>PMid:24591969 PMCid:PMC3939113</comment></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuffnell</surname><given-names>DJ</given-names></name><name><surname>Jankowicz</surname><given-names>D</given-names></name><name><surname>Lindow</surname><given-names>SW</given-names></name><name><surname>Lyons</surname><given-names>G</given-names></name><name><surname>Mason</surname><given-names>GC</given-names></name><name><surname>Russell</surname><given-names>IF</given-names></name><name><surname>Walker</surname><given-names>JJ</given-names></name></person-group><article-title>and On behalf of the Yorkshire Obstetric Critical Care Group. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003</article-title><source>BJOG:An International Journal of Obstetrics &#x00026; Gynaecology</source><year>2005</year><volume>112</volume><fpage>875</fpage><lpage>880</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1111/j.1471-0528.2005.00565ax">http://dx.doi.org/10.1111/j.1471-0528.2005.00565ax</uri></comment><comment>PMid:15957986</comment><pub-id pub-id-type="pmid">15957986</pub-id></element-citation></ref></ref-list></back></article>